BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10403412)

  • 1. Investigation of the types and characteristics of the proteolytic enzymes formed by diverse strains of Proteus species.
    Senior BW
    J Med Microbiol; 1999 Jul; 48(7):623-628. PubMed ID: 10403412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of IgA protease production among clinical isolates of Proteeae.
    Senior BW; Albrechtsen M; Kerr MA
    J Med Microbiol; 1988 Jan; 25(1):27-31. PubMed ID: 3275781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients.
    Loomes LM; Senior BW; Kerr MA
    Infect Immun; 1992 Jun; 60(6):2267-73. PubMed ID: 1587593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris.
    Kappos T; John MA; Hussain Z; Valvano MA
    J Clin Microbiol; 1992 Oct; 30(10):2632-7. PubMed ID: 1400963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of Proteus vulgaris biogroup 3 with recognition of Proteus hauseri sp. nov., nom. rev. and unnamed Proteus genomospecies 4, 5 and 6.
    O'Hara CM; Brenner FW; Steigerwalt AG; Hill BC; Holmes B; Grimont PA; Hawkey PM; Penner JL; Miller JM; Brenner DJ
    Int J Syst Evol Microbiol; 2000 Sep; 50 Pt 5():1869-1875. PubMed ID: 11034498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1.
    Hickman FW; Steigerwalt AG; Farmer JJ; Brenner DJ
    J Clin Microbiol; 1982 Jun; 15(6):1097-102. PubMed ID: 7050147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of superoxide dismutases from Proteus mirabilis and Proteus vulgaris.
    Dayton TM; Diefenbach KA; Fuller ML; Valtos J; Niederhoffer EC
    Biometals; 1996 Apr; 9(2):131-7. PubMed ID: 8744895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteus mirabilis strains of diverse type have IgA protease activity.
    Senior BW; Albrechtsen M; Kerr MA
    J Med Microbiol; 1987 Sep; 24(2):175-80. PubMed ID: 3309325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and typing of Proteus penneri and Proteus vulgaris biogroups 2 and 3, from clinical sources, by computerized analysis of electrophoretic protein patterns.
    Costas M; Holmes B; Frith KA; Riddle C; Hawkey PM
    J Appl Bacteriol; 1993 Nov; 75(5):489-98. PubMed ID: 8300450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].
    Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G
    Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
    Kwil I; Kaźmierczak D; Różalski A
    Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth and swarming of Proteus mirabilis and Proteus vulgaris by triclosan.
    Firehammer BD
    J Clin Microbiol; 1987 Jul; 25(7):1312-3. PubMed ID: 3301894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.
    Mobley HL; Chippendale GR; Swihart KG; Welch RA
    Infect Immun; 1991 Jun; 59(6):2036-42. PubMed ID: 2037363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of NCTC 4175, the current type strain of Proteus vulgaris, with ATCC 29905. Request for an opinion.
    Brenner DJ; Hickman-Brenner FW; Holmes B; Hawkey PM; Penner JL; Grimont PA; O'Hara CM
    Int J Syst Bacteriol; 1995 Oct; 45(4):870-1. PubMed ID: 7547312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
    Kotelko K; Kaca W; Rózalski A; Deka M
    Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship.
    Shikh-Bardsiri H; Shakibaie MR
    Pak J Biol Sci; 2013 Nov; 16(22):1496-502. PubMed ID: 24511691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique developmental characteristics of the swarm and short cells of Proteus vulgaris and Proteus mirabilis.
    Falkinham JO; Hoffman PS
    J Bacteriol; 1984 Jun; 158(3):1037-40. PubMed ID: 6427187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1980 Sep; 12(3):304-9. PubMed ID: 7012166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lecithinase activity of Proteus vulgaris.
    Postupa R; Postupová M
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):227-31. PubMed ID: 3045200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.